BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
bal pharma ltd. stock

BAL PHARMA LTD. Share Price

121 -1.33 (-1.08%)
Dec 13 2024 03:14 PM Pharmaceuticals NSE: BALPHARMA

BAL PHARMA LTD. Share Price Update

As of the latest trading session, BAL PHARMA LTD. share price is currently at 121, which is down by -1.33 from its previous closing. Today, the stock has fluctuated between 119.89 and 121.00. Over the past year, BAL PHARMA LTD. has achieved a return of 28.92 %. In the last month alone, the return has been 17.67 %. Read More...

BAL PHARMA LTD. Performance

Day Range

Low119.89 High121.00
131.71

52 Week Range

Low 88.95 High 157.98
131.71

BAL PHARMA LTD. Share Price

13444

524824

BALPHARMA

img img img img
No Data Available

Open Price

121.00

Prev. Close

122.34

Volume (Shares)

3365.00

Total traded value

4.43

Upper Circuit

124.78

Lower Circuit

119.89

Note: The current prices & values are delayed, Login to your account for live updates.

BAL PHARMA LTD. Fundamentals


(Standalone)

Market Cap (Cr) 191.23
PE Ratio (TTM) 19.20
Book Value / Share 66.38
Beta 0.88
ROE 10.19%
EPS (TTM) 6.80
Dividend Yield 0.91%
Net Profit Qtr (Cr) 1.75

BAL PHARMA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 73.13
Operating Expense 71.83
Net Profit 1.75
Net Profit Margin (%) 2.39
Earnings Per Share (EPS) 1.11
EBITDA 7.90
Effective Tax Rate (%) 17.06
Particulars MAR 2024 (Values in Cr)
Revenue 94.58
Operating Expense 90.15
Net Profit 6.22
Net Profit Margin (%) 6.57
Earnings Per Share (EPS) 4.16
EBITDA 12.54
Effective Tax Rate (%) 6.74
Particulars DEC 2023 (Values in Cr)
Revenue 81.50
Operating Expense 80.07
Net Profit 1.26
Net Profit Margin (%) 1.54
Earnings Per Share (EPS) 0.80
EBITDA 7.78
Effective Tax Rate (%) 25.14
Particulars SEP 2023 (Values in Cr)
Revenue 92.30
Operating Expense 90.47
Net Profit 1.60
Net Profit Margin (%) 1.73
Earnings Per Share (EPS) 1.02
EBITDA 8.07
Effective Tax Rate (%) 28.25
Particulars JUN 2023 (Values in Cr)
Revenue 70.17
Operating Expense 69.09
Net Profit 1.20
Net Profit Margin (%) 1.71
Earnings Per Share (EPS) 0.76
EBITDA 7.29
Effective Tax Rate (%) 22.22
Particulars MAR 2024 (Values in Cr)
Revenue 338.54
Operating Expense 329.79
Net Profit 10.27
Net Profit Margin (%) 3.03
Earnings Per Share (EPS) 6.72
EBITDA 35.80
Effective Tax Rate (%) 15.11
Particulars MAR 2023 (Values in Cr)
Revenue 303.10
Operating Expense 296.73
Net Profit 6.13
Net Profit Margin (%) 2.02
Earnings Per Share (EPS) 3.90
EBITDA 28.49
Effective Tax Rate (%) 28.30
Particulars MAR 2022 (Values in Cr)
Revenue 280.37
Operating Expense 274.79
Net Profit 8.58
Net Profit Margin (%) 3.06
Earnings Per Share (EPS) 5.79
EBITDA 29.70
Effective Tax Rate (%) 28.85
Particulars MAR 2021 (Values in Cr)
Revenue 249.31
Operating Expense 242.21
Net Profit 9.10
Net Profit Margin (%) 3.65
Earnings Per Share (EPS) 6.41
EBITDA 29.02
Effective Tax Rate (%) 7.14
Particulars MAR 2020 (Values in Cr)
Revenue 170.67
Operating Expense 183.38
Net Profit -8.90
Net Profit Margin (%) -5.21
Earnings Per Share (EPS) -6.28
EBITDA 10.50
Effective Tax Rate (%) 1.87
Particulars MAR 2024 (Values in Cr)
Book Value / Share 43.42
ROE % 11.20
ROCE % 11.74
Total Debt to Total Equity 2.03
EBITDA Margin 10.19
Particulars MAR 2023 (Values in Cr)
Book Value / Share 40.66
ROE % 4.28
ROCE % 9.16
Total Debt to Total Equity 1.92
EBITDA Margin 8.61
Particulars MAR 2022 (Values in Cr)
Book Value / Share 38.92
ROE % 9.04
ROCE % 11.02
Total Debt to Total Equity 1.90
EBITDA Margin 9.92
Particulars MAR 2021 (Values in Cr)
Book Value / Share 35.52
ROE % 8.89
ROCE % 9.32
Total Debt to Total Equity 2.16
EBITDA Margin 10.29
Particulars MAR 2020 (Values in Cr)
Book Value / Share 36.99
ROE % -21.65
ROCE % -0.43
Total Debt to Total Equity 2.03
EBITDA Margin 4.02
Particulars MAR 2024 (Values in Cr)
Book Value / Share 66.81
ROE % 10.19
ROCE % 11.63
Total Debt to Total Equity 1.28
EBITDA Margin 10.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 61.21
ROE % 6.69
ROCE % 10.08
Total Debt to Total Equity 1.22
EBITDA Margin 9.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 58.28
ROE % 9.36
ROCE % 11.20
Total Debt to Total Equity 1.21
EBITDA Margin 10.22
Particulars MAR 2021 (Values in Cr)
Book Value / Share 52.88
ROE % 12.53
ROCE % 12.18
Total Debt to Total Equity 1.40
EBITDA Margin 11.75
Particulars MAR 2020 (Values in Cr)
Book Value / Share 46.53
ROE % -12.46
ROCE % 2.03
Total Debt to Total Equity 1.43
EBITDA Margin 6.23
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.29
Total Assets 319.52
Total Liabilities 319.52
Total Equity 69.26
Share Outstanding 15804372
Price to Book Ratio 1.37
Return on Assets (%) 2.31
Return on Capital (%) 3.54
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 7.61
Total Assets 313.17
Total Liabilities 313.17
Total Equity 63.70
Share Outstanding 15689872
Price to Book Ratio 1.09
Return on Assets (%) 0.82
Return on Capital (%) 1.32
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.39
Total Assets 260.53
Total Liabilities 260.53
Total Equity 58.49
Share Outstanding 14823720
Price to Book Ratio 1.85
Return on Assets (%) 2.15
Return on Capital (%) 3.59
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.85
Total Assets 240.08
Total Liabilities 240.08
Total Equity 53.35
Share Outstanding 14823720
Price to Book Ratio 1.02
Return on Assets (%) 1.97
Return on Capital (%) 3
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.13
Total Assets 238.38
Total Liabilities 238.38
Total Equity 45.33
Share Outstanding 14172372
Price to Book Ratio 0.70
Return on Assets (%) -5.12
Return on Capital (%) -7.73
Particulars MAR 2024 (Values in Cr)
Net Income 9.04
Cash from Operations 27.34
Cash from Investing -18.89
Cash from Financing -1.20
Net change in Cash 2.70
Free Cash Flow 38.31
Particulars MAR 2023 (Values in Cr)
Net Income 4.74
Cash from Operations -1.03
Cash from Investing -22.18
Cash from Financing 24.09
Net change in Cash 0.37
Free Cash Flow 13.61
Particulars MAR 2022 (Values in Cr)
Net Income 9.18
Cash from Operations 27.99
Cash from Investing -9.48
Cash from Financing -17.22
Net change in Cash 0.08
Free Cash Flow 36.46
Particulars MAR 2021 (Values in Cr)
Net Income 4.10
Cash from Operations 22.44
Cash from Investing -5.53
Cash from Financing -16.63
Net change in Cash 0.16
Free Cash Flow 22.44
Particulars MAR 2020 (Values in Cr)
Net Income -13.52
Cash from Operations 23.41
Cash from Investing -4.70
Cash from Financing -19.97
Net change in Cash -1.43
Free Cash Flow 23.41
Particulars MAR 2024 (Values in Cr)
Net Income 12.10
Cash from Operations 33.49
Cash from Investing -18.42
Cash from Financing -7.71
Net change in Cash 2.80
Free Cash Flow 43.99
Particulars MAR 2023 (Values in Cr)
Net Income 8.54
Cash from Operations 5.87
Cash from Investing -22.08
Cash from Financing 17.12
Net change in Cash 0.41
Free Cash Flow 20.41
Particulars MAR 2022 (Values in Cr)
Net Income 12.05
Cash from Operations 31.68
Cash from Investing -13.43
Cash from Financing -17.21
Net change in Cash -0.07
Free Cash Flow 39.25
Particulars MAR 2021 (Values in Cr)
Net Income 9.79
Cash from Operations 10.34
Cash from Investing -6.65
Cash from Financing -3.36
Net change in Cash 0.21
Free Cash Flow 13.15
Particulars MAR 2020 (Values in Cr)
Net Income -9.07
Cash from Operations 21.88
Cash from Investing -3.15
Cash from Financing -19.93
Net change in Cash -1.37
Free Cash Flow 25.48
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 57.48 33.03 3.13 440.49 37.54 / 77.70
BLISS GVS PHARMA LTD 133.95 16.76 1.39 1410.52 92.25 / 148.95
CIPLA LTD 1493.35 26.13 4.25 120602.27 1188.35 / 1702.00
FERMENTA BIOTECH LIMITED 369.80 128.40 3.74 1088.36 145.00 / 399.60
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 57.48 49.98 9.77 440.49 37.54 / 77.70
AMRUTAJAN HEALTH LTD 713.95 43.43 6.93 2064.07 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6463.15 125.52 23.78 16157.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 133.95 17.44 1.37 1410.52 92.25 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 132.60
  • 26 Days 127.20
  • 10 Days 129.50
  • 50 Days 128.50
  • 12 Days 129.00
  • 100 Days 126.70
  • 20 Days 125.60
  • 200 Days 123.70
131.71
PIVOT
First Resistance 131.71
Second Resistance 131.71
Third Resistance 131.71
First Support 131.71
Second Support 131.71
Third Support 131.71
RSI 55.68
MACD 1.82
Commodity Channel Index (CCI) 105.63
ADX 34.72
Williams % R -34.16

Over 1 Month

down

17.67

Over 3 Months

down

-8.68

Over 6 Months

down

34.06

Over 1 Year

down

28.92

Over 3 Years

down

9.52

Over 5 Years

down

27.74

BAL PHARMA LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

BAL PHARMA LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
49.0
Promoter Holdings
50.85
FII
0.13
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Shailesh Siroya Shareholding of Promoter and Promoter Group 2745459.0 17.24
Micro Labs Limited Shareholding of Promoter and Promoter Group 2011736.0 12.64
Anita Siroya Shareholding of Promoter and Promoter Group 1049220.0 6.59
Prakash Chandra Jain Public Shareholding 581270.0 3.65
Ram Keshav Murthy Public Shareholding 527600.0 3.31
Anand Surana Shareholding of Promoter and Promoter Group 525686.0 3.3
Chandraprakash Dheerajmal Siroya Shareholding of Promoter and Promoter Group 486420.0 3.06
Dilip Surana Shareholding of Promoter and Promoter Group 474994.0 2.98
Naresh D P Public Shareholding 300000.0 1.88
Shreya Mardia Public Shareholding 300000.0 1.88
Asha Tapidas Dhodia Public Shareholding 293247.0 1.84
Archana Surana Shareholding of Promoter and Promoter Group 284996.0 1.79
Gautam Chand Mehta Public Shareholding 189966.0 1.19
Monica Surana Shareholding of Promoter and Promoter Group 179909.0 1.13
Dilip Surana (huf) Shareholding of Promoter and Promoter Group 169995.0 1.07
Anita Chandraprakash Siroya Shareholding of Promoter and Promoter Group 122687.0 0.77
Jivi Dheerajmal Siroya Shareholding of Promoter and Promoter Group 46080.0 0.29
Shrenik D Siorya Shareholding of Promoter and Promoter Group 0.0 0.0

BAL PHARMA LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-09-18 1.2 Final 2024-09-19 Equity shares 2023-09-18 1.0 Final 2023-09-19 Equity shares 2022-09-13 1.0 Final 2022-09-15 Equity shares 2021-09-16 1.0 Final 2021-09-18 Equity shares 2019-09-17 1.0 Final 2019-09-19 Equity shares 2018-09-14 1.0 Final 2018-09-18 Equity shares 2017-09-14 1.0 Final 2017-09-18 Equity shares 2016-09-15 1.0 Final 2016-09-18 Equity shares 2015-09-15 1.0 Final 2015-09-18 Equity shares 2014-09-12 1.0 Final 2014-09-16 Equity shares 2013-09-12 0.75 Final 2013-09-16 Equity shares 2009-09-17 0.75 Final 2009-09-22 Equity shares 2008-09-09 1.0 Final 2008-09-11 Equity shares 2007-09-07 0.75 Final 2007-09-11 Equity shares 2005-09-09 0.0 Final 2005-09-13 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About BAL PHARMA LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by BAL PHARMA LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Bal Pharma Ltd?

Answer Field

The share price of Bal Pharma Ltd for NSE is ₹ 121 and for BSE is ₹ 123.7.

What is the Market Cap of Bal Pharma Ltd?

Answer Field

The market cap of Bal Pharma Ltd for NSE is ₹ 1,91.23 Cr. and for BSE is ₹ 1,95.50 Cr. as of now.

What is the 52 Week High and Low of Bal Pharma Ltd?

Answer Field

The 52 Week High and Low of Bal Pharma Ltd for NSE is ₹ 157.98 and ₹ 88.95 and for BSE is ₹ 157.90 and ₹ 89.20.

How to Buy Bal Pharma Ltd share?

Answer Field

You can trade in Bal Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Bal Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 26.34%.

What is the Current Share Price of Bal Pharma Ltd?

Answer Field

Bal Pharma Ltd share price is for NSE ₹ 121 & for BSE ₹ 123.7 as on Dec 13 2024 03:14 PM.

What is the Market Cap of Bal Pharma Ltd Share?

Answer Field

The market cap of Bal Pharma Ltd for NSE ₹ 1,91.23 & for BSE ₹ 1,95.50 as on Dec 13 2024 03:14 PM.

What is the P/E Ratio of Bal Pharma Ltd Share?

Answer Field

As on Dec 13 2024 03:14 PM the price-to-earnings (PE) ratio for Bal Pharma Ltd share is 19.20.

What is the PB ratio of Bal Pharma Ltd Share?

Answer Field

As on Dec 13 2024 03:14 PM, the price-to-book (PB) ratio for Bal Pharma Ltd share is 66.38.

How to Buy Bal Pharma Ltd Share?

Answer Field

You can trade in Bal Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bal Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Bal Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bal Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader